enGene Therapeutics
ENGNWNasdaq CanadaHealth CareBiotechnology: Biological Products (No Diagnostic Substances)
Market cap
$13.403 M
$0.20 +10.31%
Close of 6 Nov 2026
As of 6 Nov 2026, enGene Therapeutics (ENGNW) has a market capitalization of $13.4M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.
Revenue
—
Not reported
Earnings
-$117.3M
Loss-making
Shares outstanding
67,016,316
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Other share classes
enGene Therapeutics lists more than one class of stock. Company figures above cover all classes combined.
Where these numbers come from
Share counts and financials for enGene Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.